X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

The Strategic Role of Systematic Health Care M+A in Remaking the Future of Health Care

This white paper analyzes the interplay of those middle market health care business mergers and acqu...

Read More >

How New CFIUS Rules on Critical Technology Affect CFIUS Filing Strategy

The Department of Treasury’s office that administers reviews of foreign investments in U.S. compani...

Read More >

What Employers Should Know About Distributions Under the SECURE Act

The Setting Every Community Up for Retirement Enhancement Act of 2019 (“SECURE Act”), the sweeping...

Read More >

Employer Readiness Plans in the Wake of the Coronavirus Outbreak

While world governments scramble to contain the spread of the coronavirus, businesses are fielding q...

Read More >

Updating the Mechanism on Supervising Mergers and Acquisitions in Indonesia

As in implementing regulation of Law of the Republic Indonesia No.5 of 1999 on the Prohibition of Mo...

Read More >

First Circuit Rules That Private Equity Funds Are Not Responsible For Portfolio Company Withdrawal Liability

Seyfarth Synopsis: In a long-awaited decision with significant impact for the private equity industr...

Read More >